Doximity, Inc. (DOCS)
Stock analysis · NYSE · Healthcare · Medical - Healthcare Information Services
Doximity, Inc. (DOCS) is a publicly traded company in the Healthcare sector. Latest price: $34.25. Market cap $6.10B. Trailing PE 38.48. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →You have viewed 8 SEO analysis pages
Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.
Continue with free signup1-Year Price
Earnings
Proprietary Signals
About Doximity, Inc.
Doximity, Inc. provides a digital platform, hosted in the cloud, specifically designed for healthcare practitioners throughout the United States. This platform delivers a suite of specialized tools, empowering its members to connect with peers, streamline patient treatment, conduct remote consultations, access current medical information and research, and advance their professional careers. Its primary clientele consists of pharmaceutical companies and healthcare organizations. Established in 2010, the entity initially operated as 3MD Communications, Inc. before rebranding to Doximity, Inc. in June of that year. The company's corporate headquarters are situated in San Francisco, California.
Valuation
| P/E (TTM) | 38.48× |
|---|---|
| P/S (TTM) | 9.31× |
| P/B | 6.83× |
| P/FCF (TTM) | 20.40× |
| EV / EBITDA | 24.13× |
| EV / Sales | 8.91× |
| Earnings Yield | 2.67% |
| Free Cash Flow Yield | 4.90% |
Fundamentals
| Enterprise Value | $5.84B |
|---|---|
| Revenue (TTM) | $655.57M |
| Net Income (TTM) | $163.09M |
| Free Cash Flow (TTM) | $299.29M |
| Net Debt | -$263.93M |
| Working Capital | $763.62M |
| Gross Margin | 88.07% |
| Operating Margin | 29.60% |
| Net Margin | 25.48% |
| Return on Equity | 16.95% |
| Return on Invested Capital | 15.31% |
Peers
Recent News
- Bragar Eagel & Squire, P.C. Urges Doximity, Inc. Investors to Contact the Firm Before November 16th Lead Plaintiff Deadline
- DOCS INVESTOR NOTICE: Doximity, Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit, RGRD Law Announces - November…
- DOCS Shareholder Alert: Doximity, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky
- Deadline Alert: Doximity, Inc. Investors Have Until November 16, 2026 to Seek Lead Plaintiff Role in Securities Fraud Class Action, Glancy…
- ROSEN, LEADING TRIAL COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action –…
Related
Browse more tickers: sitemap